Eric Marandett and Sophie Wang on Secondary Considerations

View “Secondary Considerations for Pharma Patents Get 2nd Look"

Eric Marandett and Sophie Wang wrote “Secondary Consideration for Pharma Patents get 2nd Look,” in IP Law360, where they discuss recent cases involving secondary considerations of non-obviousness for “secondary” or “follow on” patents, and the battle life sciences companies continue to face in defending the validity of these patents.  This also appeared in the Life Sciences and Appellate sections of Law360.